KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 153 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,827,078 | $82,205,000 | 4.43% |
| Palo Alto Investors LP | 4,663,324 | $79,416,000 | 3.21% |
| Private Capital Advisors, Inc. | 473,901 | $8,071,000 | 2.23% |
| DOHENY ASSET MANAGEMENT /CA | 215,445 | $3,669,000 | 1.92% |
| Sandia Holdings, LLC | 119,739 | $2,039,000 | 0.96% |
| Capital Impact Advisors, LLC | 102,006 | $1,744,000 | 0.60% |
| Birchview Capital, LP | 50,000 | $852,000 | 0.55% |
| EMERALD ADVISERS, LLC | 694,068 | $11,820,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 647,307 | $11,024,000 | 0.37% |
| Schonfeld Strategic Advisors LLC | 418,100 | $7,121,000 | 0.32% |